Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

Kazuya Takeda; Haruo Matsushita; Masaki Kubozono; Takaya Tanabe; Yojiro Ishikawa; Takaya Yamamoto; Maiko Kozumi; Noriyoshi Takahashi; Yu Katagiri; Shun Tasaka; Katsuya Fukui; Ken Takeda; Fumiyoshi Fujishima; Masakazu Ichinose; Keiichi Jingu

doi:10.2169/internalmedicine.55.6990

Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

Kazuya Takeda, Haruo Matsushita, Masaki Kubozono, Takaya Tanabe, Yojiro Ishikawa, Takaya Yamamoto, Maiko Kozumi, Noriyoshi Takahashi, Yu Katagiri, Shun Tasaka, Katsuya Fukui, Ken Takeda, Fumiyoshi Fujishima, Masakazu Ichinose, Keiichi Jingu

Tohoku University

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.

Original language	English
Pages (from-to)	3325-3330
Number of pages	6
Journal	Internal Medicine
Volume	55
Issue number	22
DOIs	https://doi.org/10.2169/internalmedicine.55.6990
Publication status	Published - 2016

Keywords

Chemoradiotherapy
Pulmonary sarcomatoid carcinoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2169/internalmedicine.55.6990

Cite this

@article{b021c2aa4bb64a0bb18a3ed9c961c9f5,

title = "Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma",

abstract = "Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.",

keywords = "Chemoradiotherapy, Pulmonary sarcomatoid carcinoma",

author = "Kazuya Takeda and Haruo Matsushita and Masaki Kubozono and Takaya Tanabe and Yojiro Ishikawa and Takaya Yamamoto and Maiko Kozumi and Noriyoshi Takahashi and Yu Katagiri and Shun Tasaka and Katsuya Fukui and Ken Takeda and Fumiyoshi Fujishima and Masakazu Ichinose and Keiichi Jingu",

note = "Publisher Copyright: {\textcopyright} 2016 The Japanese Society of Internal Medicine.",

year = "2016",

doi = "10.2169/internalmedicine.55.6990",

language = "English",

volume = "55",

pages = "3325--3330",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "22",

}

TY - JOUR

T1 - Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

AU - Takeda, Kazuya

AU - Matsushita, Haruo

AU - Kubozono, Masaki

AU - Tanabe, Takaya

AU - Ishikawa, Yojiro

AU - Yamamoto, Takaya

AU - Kozumi, Maiko

AU - Takahashi, Noriyoshi

AU - Katagiri, Yu

AU - Tasaka, Shun

AU - Fukui, Katsuya

AU - Takeda, Ken

AU - Fujishima, Fumiyoshi

AU - Ichinose, Masakazu

AU - Jingu, Keiichi

PY - 2016

Y1 - 2016

N2 - Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.

AB - Pulmonary sarcomatoid carcinoma is a rare subtype of non-small cell lung cancer with a poor prognosis. We herein report on a case of pulmonary sarcomatoid carcinoma that was treated successfully by concurrent chemoradiotherapy. A 65-year-old man was diagnosed to have pulmonary pleomorphic carcinoma (clinical T4N2M0 stage IIIB). He received concurrent chemoradiotherapy (60 Gy of radiotherapy in 30 fractionations and two courses of chemotherapy with carboplatin and paclitaxel). After chemoradiotherapy, a significant reduction of the tumor size was observed. Two courses of adjuvant chemotherapy were performed. He is currently alive at 15 months after the first treatment without any recurrence or metastasis.

KW - Chemoradiotherapy

KW - Pulmonary sarcomatoid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84995578264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995578264&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.55.6990

DO - 10.2169/internalmedicine.55.6990

M3 - Article

C2 - 27853077

AN - SCOPUS:84995578264

SN - 0918-2918

VL - 55

SP - 3325

EP - 3330

JO - Internal Medicine

JF - Internal Medicine

IS - 22

ER -

Definitive chemoradiotherapy for advanced pulmonary sarcomatoid carcinoma

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this